This is a guest editorial post written by our newest contributor, Larry Golbom R.Ph MBA of the Prescription Addiction Radio show. An Open Letter to the Legal Community Regarding the Overmarketing of Pain Killers by Pharmaceutical Companies Acting as Common Drug Dealers Prior to being named pain killers, the opium derived drugs were referred to as … [Read more...]
Actavis Totowa Finally Does The Right Thing
(Editorial) Actavis Totowa issued a press release (found here on the FDA website and discussed here on US Recall News) announcing a "precautionary, voluntary recall" of all drug products manufactured at its Little Falls, New Jersey facility. Back in May US Recall News uncovered an FDA report released in the summer of 2006 that outlines some of the … [Read more...]
Makers of Digitek Recall All Other Drugs
Actavis Totowa, makers of the recalled Digitek brand of digoxin, have announced a voluntary recall on all pharmaceutical drug products produced at their Little Falls, NJ drug manufacturing facility. Although Actavis Totowa states that this recall is "not prompted by product complaints or health hazards associated with the products", it comes after … [Read more...]
ETHEX Corporation Voluntarily Recalls Specific Lots of 30 mg. and 60 mg. Morphine Sulfate Extended Release Tablets
CONTACT: ANN MCBRIDE 1-800-321-1705 FOR IMMEDIATE RELEASE -- ST. LOUIS, MO – JUNE 13, 2008 – ETHEX CORPORATION ANNOUNCED TODAY THAT IT HAS VOLUNTARILY RECALLED SPECIFIC ADDITIONAL LOTS OF MORPHINE SULFATE 60 MG EXTENDED RELEASE TABLETS, AND SPECIFIC LOTS OF MORPHINE SULFATE 30 MG EXTENDED RELEASE TABLETS, AS A PRECAUTION, DUE TO THE … [Read more...]
Digoxin Toxicity
Digoxin toxicity has always been a major problem, due to the narrow range separating medically-effective digoxin levels from toxic levels of the drug. … [Read more...]
- « Previous Page
- 1
- …
- 33
- 34
- 35
- 36
- 37
- …
- 45
- Next Page »
Recent Comments